Product image of Metformin Hydrochloride Hfa Holdings (Metformin Hydrochloride) supplied by GNH India

Metformin Hydrochloride Hfa Holdings

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformin Hydrochloride Hfa Holdings (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Hfa Holdings, is a Biguanide presented as an oral dosage form for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus.

GNH India supplies Metformin Hydrochloride Hfa Holdings as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Hfa Holdings Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformin Hydrochloride is a biguanide antidiabetic agent used in the management of disorders related to insulin resistance and hyperglycaemia.

  • Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial glucose levels.
  • Prediabetes (impaired fasting glucose): reduces the risk of progression to overt diabetes.
  • Polycystic ovary syndrome (PCOS): enhances insulin sensitivity and may help regulate menstrual cycles.

How It Works

  • Metformin Hydrochloride primarily inhibits hepatic gluconeogenesis, thereby decreasing hepatic glucose output. It also reduces intestinal glucose absorption and increases peripheral insulin sensitivity by activating AMP‑activated protein kinase (AMPK), which enhances glucose uptake in muscle and adipose tissue without stimulating insulin secretion.

Side Effects

Metformin Hydrochloride is associated with several adverse reactions that vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhoea: frequent loose stools, especially during treatment initiation.
  • Abdominal discomfort: cramping or bloating.
  • Metallic taste: transient alteration of taste perception.
  • Weight loss: modest reduction in body weight.
  • Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: rare but potentially fatal metabolic acidosis.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatotoxicity: liver enzyme elevations or injury.
  • Hypoglycaemia: when combined with other glucose‑lowering agents.
  • Pancreatitis: inflammation of the pancreas reported infrequently.
  • Severe allergic reactions: anaphylaxis or angioedema.

Precautions & Warnings

Metformin Hydrochloride requires careful assessment of patient-specific factors before initiation.

  • Renal function: evaluate creatinine clearance; avoid in severe renal impairment.
  • Hepatic function: monitor liver enzymes; use caution in hepatic disease.
  • Lactic acidosis risk: discontinue before radiographic contrast studies.
  • Elderly patients: start at lower doses and monitor for accumulation.
  • Concomitant medications: review for drugs that may affect renal clearance.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metformin Hydrochloride can interact with several medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Iodinated contrast agents: increase risk of lactic acidosis; discontinue metformin before and after use.
  • Cimetidine: may raise metformin plasma concentrations.
  • Acute heart failure: can exacerbate renal dysfunction and lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycaemia symptoms.
  • Diuretics: can affect renal clearance of metformin.
  • Corticosteroids: may raise blood glucose, requiring dose adjustment.
  • ACE inhibitors/ARBs: monitor renal function and electrolytes.
  • Other antidiabetic agents (e.g., sulfonylureas): increase risk of hypoglycaemia.

Frequently Asked Questions

Metformin Hydrochloride is an oral antidiabetic medication indicated primarily for the treatment of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by decreasing hepatic glucose production, reducing intestinal absorption of glucose, and improving peripheral insulin sensitivity.

The drug activates AMP‑activated protein kinase (AMPK), which suppresses hepatic gluconeogenesis and enhances glucose uptake in muscle and fat cells. This combined action reduces the amount of glucose released into the bloodstream and improves the body’s response to insulin without directly stimulating insulin secretion.

The appropriate dose of Metformin Hydrochloride is determined by the prescribing healthcare professional based on the individual’s medical condition, renal function, and response to therapy. Patients should follow the dosage instructions provided by their prescriber and not adjust the dose on their own.

Safety of Metformin Hydrochloride in pregnancy and lactation should be evaluated by a qualified clinician. While some guidelines allow its use when benefits outweigh potential risks, the decision must be individualized, and patients should discuss any concerns with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Metformin Hydrochloride Hfa Holdings. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metformin belongs to the biguanide class and is often preferred as first‑line therapy for type 2 diabetes because it does not cause weight gain and has a low risk of hypoglycaemia when used alone. Compared with sulfonylureas or insulin, it works without stimulating insulin release and has a distinct safety profile.

Metformin Hydrochloride should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or extreme heat.

The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse effect is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or after exposure to iodinated contrast agents. Prompt medical attention is required if symptoms such as unexplained fatigue, rapid breathing, or abdominal pain develop.

Metformin is contraindicated in individuals with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those who have experienced lactic acidosis while on the drug. Clinicians should assess each patient’s medical history before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT